PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR PANTOPRAZOLE IN CHILDREN WITH OBESITY

被引：0
|
作者：
Kyler, K. [1 ]
Shakhnovich, V. [2 ]
Selvarangan, R. [1 ]
Sasidharan, A. [1 ]
Chan, S. [1 ]
Artz, N. [1 ]
Williams, V. [3 ]
Friesen, C. [4 ]
Pearce, R. [1 ]
Gaedigk, A. [1 ]
Leeder, J. [1 ]
Galetin, A. [5 ]
Johnson, T. [6 ]
机构：
[1] Childrens Mercy, Kansas City, MO USA
[2] Ironwood Pharmaceut, Boston, MA USA
[3] Nemours Childrens Hlth, Jacksonville, FL USA
[4] Univ Kansas, Med Ctr, Kansas City, KS USA
[5] Univ Manchester, Manchester, England
[6] Certara, Edinburgh, Scotland
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-175
引用
收藏
页码：S106 / S107
页数：2
相关论文
共 50 条
  • [1] A physiologically-based pharmacokinetic (PBPK) model of hydroxychloroquine
    Collins, Keagan P.
    Jackson, Kristen M.
    Gustafson, Daniel L.
    [J]. CANCER RESEARCH, 2017, 77
  • [2] Physiologically-based pharmacokinetic (PBPK) model to describe the disposition of pyronaridine
    Diep, John K.
    Lingerfelt, Mary A.
    Ekins, Sean
    Rao, Gauri G.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S34 - S34
  • [3] A physiologically-based pharmacokinetic/pharmacodynamic (PBPK/PD) model for the insecticide dimethoate
    Reiss, Richard
    Loccisano, Anne
    Deines, Andrew
    Kim, Myoungwoo
    Nallani, Gopinath
    Chandrasekaran, Appavu
    Whatling, Paul
    [J]. XENOBIOTICA, 2023, 53 (05) : 382 - 395
  • [4] Physiologically-Based Pharmacokinetic (PBPK) Modeling of Buprenorphine in Adults, Children and Preterm Neonates
    Kovar, Lukas
    Schraepel, Christina
    Selzer, Dominik
    Kohl, Yvonne
    Bals, Robert
    Schwab, Matthias
    Lehr, Thorsten
    [J]. PHARMACEUTICS, 2020, 12 (06) : 1 - 22
  • [5] A physiologically-based pharmacokinetic (PBPK) model for alcohol facilitates rapid BrAC clamping
    Ramchandani, VA
    Bolane, J
    Li, TK
    O'Connor, S
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1999, 23 (04) : 617 - 623
  • [6] A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines
    Tegenge, Million A.
    Mitkus, Robert J.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 (05) : 545 - 556
  • [7] A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines
    Million A. Tegenge
    Robert J. Mitkus
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2013, 40 : 545 - 556
  • [8] Development of Physiologically-Based Pharmacokinetic (PBPK) model for biodistribution of radiolabeled peptides in human body
    Gospavic, R.
    Knoll, P.
    Mirzaei, S.
    Popov, V.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S342 - S342
  • [9] A physiologically-based pharmacokinetic (PBPK) and pharmacodynamic (PD) model of docetaxel (Doc) and neutropenia in humans
    Florian, J. A., Jr.
    Egorin, M. J.
    Zamboni, W. C.
    Eiseman, J. L.
    Lagattuta, T. F.
    Belani, C. P.
    Chatta, G. S.
    Scher, H. I.
    Solit, D. B.
    Parker, R. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] VARIABILITY OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL PARAMETERS AND THEIR EFFECTS ON PBPK MODEL PREDICTIONS IN A RISK ASSESSMENT FOR PERCHLOROETHYLENE (PCE)
    GEARHART, JM
    MAHLE, DA
    GREENE, RJ
    SECKEL, CS
    FLEMMING, CD
    FISHER, JW
    CLEWELL, HJ
    [J]. TOXICOLOGY LETTERS, 1993, 68 (1-2) : 131 - 144
12345